02563 BIOSTAR PHARM-B
Trading Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 8.83X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 0.1% | Net Margin | N/A |
| Total Debt/Equity | 0.2% | Return on Equity | N/A |
| Price/Book | 3.35X | Return on Assets | N/A |
| (HKD 7.720) | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | -152.91 | -209.03 | -179.96 |
|---|---|---|---|
| Net Profit Growth (%) | +26.9 | -16.2 | N/A |
| Earnings Per Share (HKD) | -0.434 | -0.597 | -0.514 |
| Earnings Per Share Growth (%) | +27.4 | -16.1 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A |
| Book NAV (HKD) | 2.307 | N/A | N/A |
| Auditors' Opinion | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 71.866 | 66.635 | +7.9 | 32.82 |
| Operating Result | -143.776 | -189.644 | -24.2 | -160.511 |
| Profit Before Taxation | -143.776 | -189.644 | -24.2 | -160.511 |
| Profit /( Loss) After Taxation | -143.776 | -189.644 | -24.2 | -160.511 |
| Net Profit | -143.776 | -189.644 | -24.2 | -160.511 |
| Earnings Per Share () | -0.4338 | -0.5972 | -27.4 | -0.5142 |
| Announcement Date | 2025-06-30 | 2024-10-23 | NA | 2024-10-23 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
